Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Riccardo PigliucciN/A653,4631.32%2005-11-22
Ms. Adelene Q. PerkinsN/A359,4320.73%2015-06-25
Julian AdamsN/A262,9430.53%2008-10-28
Dr. Anthony B. Evnin,PhDN/A107,0910.22%2016-06-17
Craig KussmanN/A85,0000.17%2004-07-12
Dr. Eric S. Lander,PhDN/A80,3190.16%2016-06-17
Dr. Michael C. Venuti,PhDN/A56,2500.11%2013-03-06
John LilligN/A46,000less than 0.1%2004-07-12
Urs RegenassN/A44,000less than 0.1%2004-07-12
Richard NealeN/A39,635less than 0.1%2006-08-14

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Perkins Adelene QPresident & CEO
(Click for the stocks that their CEOs have bought)
2015-06-25Sell5,000366,265$10.9354.65-85.91359,432 (Direct)
6,833 (By 401(k))
Palombella Vito J.Chief Scientific Officer2015-06-15Sell4,7377,609$10.9751.96-85.96868 (Direct)
6,741 (By 401(k))
Perkins Adelene QPresident & CEO2015-05-27Sell10,000371,265$12.81128.1-87.98364,432 (Direct)
6,833 (By 401(k))
Perkins Adelene QPresident & CEO2015-05-14Sell10,000381,265$12.18121.8-87.36374,432 (Direct)
6,833 (By 401(k))
Perkins Adelene QPresident & CEO2015-03-16Sell20,000390,950$16320-90.38384,432 (Direct)
6,518 (By 401(k))
Perkins Adelene QPresident & CEO2015-03-05Sell25,000410,950$16.5412.5-90.67404,432 (Direct)
6,518 (By 401(k))
Perkins Adelene QPresident & CEO2015-01-29Sell20,000434,053$14.83296.6-89.62427,535 (Direct)
6,518 (By 401(k))
Perkins Adelene QPresident & CEO2015-01-29Sell20,000429,432$14.83296.6-89.62429,432 (Direct)
Palombella Vito J.Chief Scientific Officer2014-12-15Sell4,7376,544$16.3277.31-90.56
6,544 (By 401k)
Palombella Vito J.Chief Scientific Officer2014-11-26Sell4,7366,544$1571.04-89.73
6,544 (By 401k)
EVNIN ANTHONY BDirector2014-09-30Sell112,45167,400$13.561524.84-88.6467,400 (Direct)
0 (By Funds)
Palombella Vito J.Chief Scientific Officer2014-09-03Sell9,4726,388$15.39145.77-89.99
6,388 (By 401k)
Palombella Vito J.Chief Scientific Officer2014-07-01Sell8796,147$12.8711.31-88.03
6,147 (By 401k)
Palombella Vito J.Chief Scientific Officer2014-02-25Sell4,7365,921$1571.04-89.73
5,921 (By 401k)
Palombella Vito J.Chief Scientific Officer2014-01-02Sell7535,923$13.5210.18-88.61
5,923 (By 401k)
EVNIN ANTHONY BDirector2013-12-02Sell17,756179,851$14.56258.53-89.4267,400 (Direct)
112,451 (By Funds)
EVNIN ANTHONY BDirector2013-11-27Sell163,864197,607$14.822428.46-89.6167,400 (Direct)
130,207 (By Funds)
Palombella Vito J.Chief Scientific Officer2013-09-27Sell4,7365,923$17.2881.84-91.09
5,923 (By 401k)
Perkins Adelene QPres & CEO2013-09-13Sell45,000453,417$20.72932.4-92.57447,535 (Direct)
5,882 (By 401k)
Palombella Vito J.Chief Scientific Officer2013-06-20Sell23,1505,657$18.53428.97-91.69
5,657 (By 401k)
Beacon Co10% Owner2013-04-16Sell5,708,2820$38.4219198.03-95.99Link
Rosebay Medical Co L.P.10% Owner2013-04-16Sell5,708,2830$38.4219198.07-95.99Link
EVNIN ANTHONY BDirector2012-11-29Sell22,480294,071$25.14565.15-93.87
294,071 (By Funds and LLC)
Lindblom Christopher MSee Remarks2012-11-26Sell13,8852,158$25.73357.26-94.01
2,158 (401(k))
Rosebay Medical Co L.P.10% Owner2012-09-07Buy5,416,5658,416,565$14.578540.19-89.383,000,000 (Direct)
5,416,565 (By Purdue Pharma L.P.)
Beacon Co10% Owner2012-09-07Buy5,416,5658,416,565$14.578540.19-89.383,000,000 (Direct)
5,416,565 (By Purdue Pharma L.P.)
Holtzman Steven HDirector2012-05-31Sell57,5733,945$13.01749.02-88.16
3,945 (By IRA)
Holtzman Steven HDirector2012-05-30Sell200,261238,882$132603.39-88.1557,573 (Direct)
3,945 (By IRA)
177,364 (By Holtzman-Stewart 1996 Irrevocable Trust)
Perkins Adelene QPres & CEO2010-12-16Buy25,000316,538$6.1152.5-74.75Link
Perkins Adelene QPres & CEO2010-08-25Buy50,000291,538$4.9245-68.57Link
Beacon Co10% Owner2009-01-07Buy1,000,0003,000,000$1515000-89.73
Rosebay Medical Co L.P.10% Owner2009-01-07Buy1,000,0003,000,000$1515000-89.73
Perkins Adelene QPres & Chief Business Officer2008-12-17Buy9,200241,538$7.972.68-80.51
Perkins Adelene QPres & Chief Business Officer2008-11-25Buy22,041232,338$6.16135.77-75
Holtzman Steven HPresident and CEO, Director2008-08-27Buy22,103256,926$7.4163.56-79.19
Perkins Adelene QEVP and Chief Business Officer2008-03-17Buy776210,297$5.914.59-73.94
Holtzman Steven HChairman and CEO, Director2007-09-14Buy5,000234,823$9.1245.6-83.11
Perkins Adelene QEVP and Chief Business Officer2007-06-15Buy10,000209,521$10.64106.4-85.53
Perkins Adelene QEVP and Chief Business Officer2007-05-11Buy6,446199,521$10.8670-85.82
Perkins Adelene QEVP and Chief Business Officer2007-05-07Buy15,148193,075$11.03167.08-86.04
Perkins Adelene QEVP and Chief Business Officer2007-05-04Buy9,100187,027$11.08100.83-86.1

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK